Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The screenshot updates are limited to minor UI/layout changes; all core study content, eligibility criteria, outcomes, and contact details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-21T06:17:23.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 removed; these are minor version labels displayed on the page and do not affect content or functionality — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-14T03:51:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added and updated the results section for NCT03230318, including primary and secondary outcomes (ORR, PFS, OS, DoR) and safety data (TEAEs). Updated primary completion and study completion dates.
    Difference
    0.1%
    Check dated 2026-01-07T02:01:56.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    No significant changes detected in the Study Details page; the content, including eligibility criteria and outcome measures, remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-31T00:02:03.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now presents a consolidated 'Locations' section with listed sites (Arizona, Florida, Georgia, Minnesota, New York, Pennsylvania, Tennessee, Texas, Washington, Alberta, Ontario) and removes the prior per-state headers (e.g., 'Arizona Locations'). The revision has been updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T22:53:55.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The new screenshot shows a layout refresh while preserving all core study details (title, brief summary, eligibility criteria, outcomes, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-16T22:03:04.000Z thumbnail image

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.